Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label mitapivat study in adults with non-transfusion-dependent thalassemia
2018-002217-35Phase 2Unknown
- Sponsor
- Agios Pharmaceuticals
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitapivat in Thalassaemia, sponsored by Agios Pharmaceuticals. Primary endpoint: Hemoglobin response. Status: unknown.
02
Drugs
mitapivat
03
Conditions
Thalassaemia
Beyond the preview
Go deeper on 2018-002217-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002217-35.